Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

British Columbia Expands Coverage Under PharmaCare Plan for New Drug for Hepatitis C

March 30, 2012

British Columbia's government has announced that its PharmaCare plan will begin providing boceprevir for hepatitis C patients who meet certain eligibility requirements. Known by the trade names Victrelis and Victrelis Triple, the medication is used in combination with other drugs and has been shown to boost cure rates by up to 25 percent. Boceprevir gained Health Canada approval last summer. Providing the drug will cost up to $50 million (US $50 million) during the next three years, the government said.

Back to other news for March 2012

Adapted from:
Canadian Press
03.26.2012


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More News and Articles on HIV Groups and Medical Care in Canada
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement